New Ipswich, NH, United States of America

Friedericke Kazo

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Hemoglobin Compositions by Friedericke Kazo

Introduction

Friedericke Kazo is an accomplished inventor based in New Ipswich, NH (US). She has made significant contributions to the field of medical science, particularly in the development of hemoglobin compositions. With a total of two patents to her name, her work focuses on enhancing oxygen delivery in medical applications.

Latest Patents

Kazo's latest patents revolve around PEGylated hemoglobin compositions. These inventions provide formulations that contain hemoglobin capable of transferring oxygen or carbon monoxide to tissues in proximity. The PEGylated hemoglobin molecules are designed to be virally inactivated, ensuring safety in medical use. The compositions can be formulated as hypo-, iso-, or hypertonic solutions, making them versatile for treating various diseases and injuries by improving tissue oxygenation.

Career Highlights

Friedericke Kazo is associated with Prolong Pharmaceuticals, LLC, where she continues to innovate in the field of hemoglobin research. Her work has the potential to significantly impact medical treatments and improve patient outcomes.

Collaborations

Kazo collaborates with notable colleagues, including Abraham Abuchowski and Glenn Kazo, who contribute to her research and development efforts.

Conclusion

Friedericke Kazo's innovative work in hemoglobin compositions showcases her dedication to advancing medical science. Her contributions are poised to enhance therapeutic options for patients in need of improved oxygenation solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…